- Home
- NTRP vs GOVX Comparison
NTRP vs GOVX Comparison
Compare NTRP & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- GOVX
- Stock Information
- Founded
- NTRP 1985
- GOVX 2001
- Country
- NTRP United States
- GOVX United States
- Employees
- NTRP N/A
- GOVX N/A
- Industry
- NTRP
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- NTRP
- GOVX Health Care
- Exchange
- NTRP NYSE
- GOVX Nasdaq
- Market Cap
- NTRP 12.7M
- GOVX 15.1M
- IPO Year
- NTRP N/A
- GOVX N/A
- Fundamental
- Price
- NTRP $3.55
- GOVX $0.50
- Analyst Decision
- NTRP Hold
- GOVX Strong Buy
- Analyst Count
- NTRP 1
- GOVX 5
- Target Price
- NTRP $5.00
- GOVX $12.40
- AVG Volume (30 Days)
- NTRP 50.0K
- GOVX 2.6M
- Earning Date
- NTRP 05-29-2025
- GOVX 08-05-2025
- Dividend Yield
- NTRP N/A
- GOVX N/A
- EPS Growth
- NTRP N/A
- GOVX N/A
- EPS
- NTRP N/A
- GOVX N/A
- Revenue
- NTRP $501,422.00
- GOVX $5,591,576.00
- Revenue This Year
- NTRP $2,544.87
- GOVX N/A
- Revenue Next Year
- NTRP N/A
- GOVX N/A
- P/E Ratio
- NTRP N/A
- GOVX N/A
- Revenue Growth
- NTRP 9.30
- GOVX N/A
- 52 Week Low
- NTRP $1.39
- GOVX $0.43
- 52 Week High
- NTRP $8.50
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- NTRP 58.20
- GOVX 29.07
- Support Level
- NTRP $3.24
- GOVX $0.43
- Resistance Level
- NTRP $3.98
- GOVX $0.98
- Average True Range (ATR)
- NTRP 0.44
- GOVX 0.14
- MACD
- NTRP 0.02
- GOVX -0.06
- Stochastic Oscillator
- NTRP 45.83
- GOVX 5.21
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.